PET/CT Imaging of Integrin αvβ3 Expression in Human Carotid Atherosclerosis

Go, 2013, Heart disease and stroke statistics—2013 update: a report from the American Heart Association, Circulation, 127, e6, 10.1161/CIR.0b013e31828124ad Ross, 1999, Atherosclerosis: an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323 Virmani, 2005, Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage, Arterioscler Thromb Vasc Biol, 25, 2054, 10.1161/01.ATV.0000178991.71605.18 Vicenzini, 2009, Imaging of carotid plaque angiogenesis, Cerebrovasc Dis, 27, 48, 10.1159/000203126 Hatsukami, 2010, MRI in the early identification and classification of high-risk atherosclerotic carotid plaques, Imaging Med, 2, 63, 10.2217/iim.09.33 Sun, 2012, Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study, J Am Coll Cardiol Img, 5, 798, 10.1016/j.jcmg.2012.03.014 Truijman, 2013, Combined 18F-FDG PET-CT and DCE-MRI to assess inflammation and microvascularization in atherosclerotic plaques, Stroke, 44, 3568, 10.1161/STROKEAHA.113.003140 Ripa, 2013, Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT, Am J Nucl Med Mol Imaging, 3, 361 Tawakol, 2006, In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients, J Am Coll Cardiol, 48, 1818, 10.1016/j.jacc.2006.05.076 Rudd, 2008, Imaging atherosclerotic plaque inflammation, Nat Clin Pract Cardiovasc Med, S11, 10.1038/ncpcardio1160 Rudd, 2002, Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography, Circulation, 105, 2708, 10.1161/01.CIR.0000020548.60110.76 Hoshiga, 1995, Alpha-v-beta-3 integrin expression in normal and atherosclerotic artery, Circ Res, 77, 1129, 10.1161/01.RES.77.6.1129 Antonov, 2004, Regulation of macrophage foam cell formation by {alpha}V{beta}3 integrin: potential role in human atherosclerosis, Am J Pathol, 165, 247, 10.1016/S0002-9440(10)63293-2 Brooks, 1994, Requirement of vascular integrin alpha v beta 3 for angiogenesis, Science, 264, 569, 10.1126/science.7512751 Brooks, 1994, Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels, Cell, 79, 1157, 10.1016/0092-8674(94)90007-8 Saraste, 2009, Cardiovascular molecular imaging: an overview, Cardiovasc Res, 83, 643, 10.1093/cvr/cvp209 Razavian, 2011, Integrin-targeted imaging of inflammation in vascular remodeling, Arterioscler Thromb Vasc Biol, 31, 2820, 10.1161/ATVBAHA.111.231654 Haubner, 2001, Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography, Cancer Res, 61, 1781 Laitinen, 2009, Evaluation of {alpha}v{beta}3 integrin-targeted positron emission tomography tracer 18F-Galacto-RGD for imaging of vascular inflammation in atherosclerotic mice, Circ Cardiovasc Imaging, 2, 331, 10.1161/CIRCIMAGING.108.846865 Haukkala, 2009, 68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice, Eur J Nucl Med Mol Imaging, 36, 2058, 10.1007/s00259-009-1220-z Saraste, 2012, Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques, J Nucl Cardiol, 19, 775, 10.1007/s12350-012-9554-5 Haubner, 2005, Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD, PLoS Med, 2, e70, 10.1371/journal.pmed.0020070 Beer, 2006, Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man, Clinical Cancer Res, 12, 3942, 10.1158/1078-0432.CCR-06-0266 Beer, 2007, [18F]Galacto-RGD positron emission tomography for imaging of αvβ3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck, Clin Cancer Res, 13, 6610, 10.1158/1078-0432.CCR-07-0528 Weber, 2008, Technology insight: advances in molecular imaging and an appraisal of PET/CT scanning, Nat Clin Pract Oncol, 5, 160, 10.1038/ncponc1041 Haubner, 2004, [18F]Galacto-RGD:  synthesis, radiolabeling, metabolic stability, and radiation dose estimates, Bioconjug Chem, 15, 61, 10.1021/bc034170n Laitinen, 2009, Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques, Eur J Nucl Med Mol Imaging, 36, 73, 10.1007/s00259-008-0919-6 Heckmann D, Kessler H. Design and chemical synthesis of integrin ligands. Available at: http://www.sciencedirect.com/science/article/B7CV2-4PD42DK-P/2/c3b8f51c50831b0c617b99295c580b20. Accessed December 27, 2013. Pichler, 2005, Imaging of delayed-type hypersensitivity reaction by PET and 18F-Galacto-RGD, J Nucl Med, 46, 184 Makowski, 2008, In vivo molecular imaging of angiogenesis, targeting αvβ3 integrin expression, in a patient after acute myocardial infarction, Eur Heart J, 29, 2201, 10.1093/eurheartj/ehn129 Beer, 2005, Biodistribution and pharmacokinetics of the {alpha}v{beta}3-selective tracer 18F-Galacto-RGD in cancer patients, J Nucl Med, 46, 1333 Beer, 2008, Comparison of integrin αvβ3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-Galacto-RGD and 18F-FDG, J Nucl Med, 49, 22, 10.2967/jnumed.107.045864 Beer, 2008, Patterns of {alpha}v{beta}3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET, J Nucl Med, 49, 255, 10.2967/jnumed.107.045526 Brix, 2002, Recovery coefficients for the quantification of the arterial input functions from dynamic PET measurements: experimental and theoretical determination, Nuklearmedizin, 41, 184 Thumshirn, 2003, Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation, Chemistry, 9, 2717, 10.1002/chem.200204304 Izquierdo-Garcia, 2009, Comparison of methods for magnetic resonance-guided [18-F]Fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods, Stroke, 40, 86, 10.1161/STROKEAHA.108.521393 Waldeck, 2008, Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an {alpha}v{beta}3 integrin-targeted fluorochrome, J Nucl Med, 49, 1845, 10.2967/jnumed.108.052514 Moulton, 1999, Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice, Circulation, 99, 1726, 10.1161/01.CIR.99.13.1726 Moulton, 2003, Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis, PNAS, 100, 4736, 10.1073/pnas.0730843100 Heinonen, 2007, Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia, Circ Res, 101, 1058, 10.1161/CIRCRESAHA.107.154401 Winter, 2003, Molecular imaging of angiogenesis in early-stage atherosclerosis with {alpha}v{beta}3-integrin-targeted nanoparticles, Circulation, 108, 2270, 10.1161/01.CIR.0000093185.16083.95 Weber, 2006, Positron emission tomography as an imaging biomarker, J Clin Oncol, 24, 3282, 10.1200/JCO.2006.06.6068 Rudd, 2010, Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?, J Am Coll Cardiol, 55, 2527, 10.1016/j.jacc.2009.12.061 van Hinsbergh, 2006, Pericellular proteases in angiogenesis and vasculogenesis, Arterioscler Thromb Vasc Biol, 26, 716, 10.1161/01.ATV.0000209518.58252.17 Brooks, 1996, Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin [alpha]v[beta]3, Cell, 85, 683, 10.1016/S0092-8674(00)81235-0 Weng, 2003, β3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice, PNAS, 100, 6730, 10.1073/pnas.1137612100 Burtea, 2008, Molecular imaging of αvβ3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA, Cardiovasc Res, 78, 148, 10.1093/cvr/cvm115